375,000 Shares Mesa Laboratories, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • August 12th, 2019 • Mesa Laboratories Inc /Co • Industrial instruments for measurement, display, and control • New York
registration statement, prospectus or prospectus supplement (or an amendment or supplement thereto) with respect to any such registration, or
AMENDMENT NO. 3 Dated as of August 7, 2019 to CREDIT AGREEMENT Dated as of March 1, 2017Credit Agreement • August 12th, 2019 • Mesa Laboratories Inc /Co • Industrial instruments for measurement, display, and control • New York
THIS AMENDMENT NO. 3 (this “Amendment”) is made as of August 7, 2019 by and among Mesa Laboratories, Inc., a Colorado corporation (the “Borrower”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as Administrative Agent (the “Administrative Agent’), under that certain Credit Agreement dated as of March 1, 2017 by and among the Borrower, the other Loan Parties from time to time party thereto, the Lenders and the Administrative Agent (as further amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings given to them in the Credit Agreement.
1.375% Convertible Senior Notes due 2025 Mesa Laboratories, Inc. UNDERWRITING AGREEMENTCredit Agreement • August 12th, 2019 • Mesa Laboratories Inc /Co • Industrial instruments for measurement, display, and control • New York
The information in this pricing term sheet supplements the preliminary prospectus supplement, dated August 6, 2019 (the “Common Stock Offering Preliminary Prospectus Supplement”), of Mesa Laboratories, Inc. (the “Issuer”), relating to an offering of common stock, no par value per share (the “Common Stock”), of the Issuer (the “Common Stock Offering”), and the preliminary prospectus supplement, dated August 6, 2019 (the “Notes Offering Preliminary Prospectus Supplement,” and, together with the Common Stock Offering Preliminary Prospectus Supplement, the “Preliminary Prospectus Supplements”), of the Issuer, relating to an offering of the Issuer’s 1.375% Convertible Senior Notes due 2025 (the “Notes Offering”). The information in this pricing term sheet supersedes the information in the Preliminary Prospectus Supplements to the extent inconsistent with the information in the Preliminary Prospectus Supplements. Terms used, but not defined, in this pricing term sheet have the respective mea
MESA LABORATORIES, INC. and WELLS FARGO BANK, NATIONAL ASSOCIATION as TrusteeFirst Supplemental Indenture • August 12th, 2019 • Mesa Laboratories Inc /Co • Industrial instruments for measurement, display, and control • New York
THIS FIRST SUPPLEMENTAL INDENTURE, dated as of August 12, 2019 (the “Supplemental Indenture”), to the Indenture, dated as of August 12, 2019 (the “Base Indenture” and, as amended, modified and supplemented by this Supplemental Indenture, the “Indenture”), between Mesa Laboratories, Inc., a Colorado corporation, as issuer (the “Company”), and Wells Fargo Bank, National Association, as trustee (the “Trustee”).
